Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Nicolás Jose Rodriguez

THE TRUTH ABOUT: Cresco lab s 1q results after conference call analyst opines | History Defined

The Analyst

Following Cresco Labs’ (OTC:CRLBF) (CSE:CL) conference call, Pablo Zuanic,  from Cantor Fitzgerald kept an "Overweight" rating and maintained a 12-month price target of $19.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.